Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-17

Clinical Trial Update: A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients [Phase 3]

View source ↗

Summary

A Phase 3 study comparing tacrolimus capsules with leflunomide tablets in lupus nephritis patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leflunomide (Leflunomide)
  • Tacrolimus (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Lupus Nephritis | Phase 3 | Status: TERMINATED